CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01681 CONSUN PHARMA

Not Yet Opened 04-08 16:08:19

17.080

+0.010

+0.06%

High17.540	Low17.000	Vol2.31M
Open17.200	D1 Closing17.070	Amplitude3.16%
Mkt Cap14.38B	Tradable Cap14.38B	Total Shares842.00M
T/O39.63M	T/O Rate0.27%	Tradable Shares842.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"CONSUN PHARMA","latestPrice":17.08,"timestamp":1775635699003,"preClose":17.07,"halted":0,"volume":2306853,"delay":0,"changeRate":0.0005858230814292918,"floatShares":842000000,"shares":842000000,"eps":1.4440195502502526,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"04-08 16:08:19","open":17.2,"high":17.54,"low":17,"amount":39625356,"amplitude":0.031634,"askPrice":17.08,"askSize":28000,"bidPrice":17.06,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":1.4440195502502526,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":0,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":17.07,"dividendRate":0.043437,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":0.9043104132871437,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681/tweets","defaultTab":"tweets","newsList":[{"id":"1113630500","title":"Strong Fundamentals and Inclusion in Stock Connect Create Key Investment Window for Consun Pharma (01681)","url":"https://stock-news.laohu8.com/highlight/detail?id=1113630500","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113630500?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:36","pubTimestamp":1775561809,"startTime":"0","endTime":"0","summary":"Recent policy support has been favorable for both traditional Chinese medicine and innovative drugs this year. During the Two Sessions, the government work report emphasized \"advancing the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195563694","title":"CONSUN PHARMA Adds 124,000 Shares in March Through Option Exercise; Public Float Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1195563694","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195563694?lang=en_us&edition=fundamental","pubTime":"2026-04-02 12:24","pubTimestamp":1775103859,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited’s monthly return for the period ended 31 March 2026 shows a net issuance of 124,000 ordinary shares, lifting the total outstanding share count to approximately...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384552","title":"Consun Pharmaceutical Group (SEHK:1681) Earnings Growth And 31.5% Margins Challenge Valuation Skeptics","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384552","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384552?lang=en_us&edition=fundamental","pubTime":"2026-03-28 20:11","pubTimestamp":1774699865,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group (SEHK:1681) opened FY 2025 with first half revenue of C¥1.57b and basic EPS of C¥0.59, set against trailing twelve month revenue of C¥3.42b and EPS of C¥1.27 that reflect earnings growth of 18.4% over the past year. The company has seen revenue move from C¥2.97b to C¥3.42b on a trailing basis, while EPS has gone from C¥1.11 to C¥1.27, supported by a trailing net profit margin of 31.5% that edges above last year’s 30.7%. This keeps profitability squarely in focus...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-earnings-growth-and-315","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-earnings-growth-and-315","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622005839","title":"BRIEF-Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005839","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005839?lang=en_us&edition=fundamental","pubTime":"2026-03-26 15:12","pubTimestamp":1774509120,"startTime":"0","endTime":"0","summary":"BRIEF-Consun Pharmaceutical Logs FY Revenue RMB 3,420 MlnMarch 26 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK:FY REVENUE RMB 3,420 MILLIONFINAL DIVIDEND OF HKD0.40 PER SHAREPROFIT ATTRIBUTABLE FOR YEAR RMB1.08 BILLIONFurther company coverage: 1681.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130311766","title":"Consun Pharma to Distribute Final Dividend of HK$0.4 Per Share on June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1130311766","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130311766?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:42","pubTimestamp":1774500131,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group announced that it will pay a final dividend of HK$0.4 per share on June 22, 2026.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK4588","BK1606","VIG","BK4585","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143021140","title":"Consun Pharma Reports 18.41% Rise in Annual Profit Attributable to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1143021140","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143021140?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:11","pubTimestamp":1774498269,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group announced its annual results for the year ended December 31, 2025. The group recorded revenue of RMB 3.417 billion, an increase of 15.17% compared to the previous year....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880189","title":"Consun Pharmaceutical FY2025 final dividend proposed at HKD 0.4 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880189?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:03","pubTimestamp":1774497838,"startTime":"0","endTime":"0","summary":"Shareholder approval is scheduled for May 26, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3GDpd4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880991","title":"Consun Pharmaceutical FY2025 profit attributable to equity shareholders climbs 18.4% to RMB1.08 billion; revenue grows 15.2% to RMB3.42 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880991","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880991?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:01","pubTimestamp":1774497693,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical FY2025 profit attributable to equity shareholders climbs 18.4% to RMB1.08 billion; revenue grows 15.2% to RMB3.42 billion. Consun Pharmaceutical published an annual results announcement reporting revenue of RMB3.42 billion, up 15.2%.Profit attributable to equity shareholders was RMB1.08 billion, up 18.4%.Basic earnings per share were RMB1.27, up 14.4%.The board proposed a final dividend of HKD0.40 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL36yyc7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622984880","title":"Consun Pharmaceutical Group Ltd - Final Dividend of HKD0.40 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622984880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622984880?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1606","BK1191","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880987","title":"Consun Pharmaceutical - Profit Attributable for Year RMB1.08 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880987?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497624,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622809898","title":"Consun Pharmaceutical Group FY Revenue RMB 3,420 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622809898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622809898?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123189330","title":"Consun Pharma (01681) Announces Board Meeting on 26 March 2026 to Review Annual Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=1123189330","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123189330?lang=en_us&edition=fundamental","pubTime":"2026-03-05 17:29","pubTimestamp":1772702980,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of the following announcement, make no representation as to its accuracy...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182385449","title":"Consun Pharmaceutical (01681) Announces Monthly Equity Movements for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1182385449","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182385449?lang=en_us&edition=fundamental","pubTime":"2026-03-02 17:25","pubTimestamp":1772443546,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited (01681) reported no changes in its authorized share capital for February 2026, remaining at 5,000,000,000 ordinary shares at HKD 0.1 par value each, with total...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143010672","title":"CONSUN PHARMA (01681) Included in Hang Seng Composite Index, Poised for Southbound Trading Eligibility","url":"https://stock-news.laohu8.com/highlight/detail?id=1143010672","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143010672?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:08","pubTimestamp":1770980907,"startTime":"0","endTime":"0","summary":"CONSUN PHARMA (01681) has been added to the Hang Seng Composite Index, according to the quarterly review results of the Hang Seng Index Series announced by Hang Seng Indexes Company on February 13,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","VXUS","01681","BK4585","BK4588","HSCI","VT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133796848","title":"Consun Pharmaceutical (01681) Cancels 100,000 Shares According to Next Day Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=1133796848","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133796848?lang=en_us&edition=fundamental","pubTime":"2026-02-13 07:45","pubTimestamp":1770939905,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited (stock code: 01681) reported a share repurchase in its Next Day Disclosure Return dated 13 February 2026. The company’s issued share count decreased from 841.51...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197168666","title":"Consun Pharmaceutical Group Limited (01681) Announces Monthly Return on Movements in Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1197168666","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197168666?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:08","pubTimestamp":1770023296,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited (01681) published its monthly return for the period ended 31 January 2026. The total authorised share capital remained at 5,000,000,000 ordinary shares (HKD 0.1...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607075121","title":"Consun Pharmaceutical Group (SEHK:1681) Valuation Check After Expanded HK$300 Million Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2607075121","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607075121?lang=en_us&edition=fundamental","pubTime":"2026-01-31 10:25","pubTimestamp":1769826359,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group expands buyback plan\nConsun Pharmaceutical Group (SEHK:1681) has expanded its existing share repurchase plan, adding HK$100 million to the programme to allow for up to HK$300 million in potential buybacks funded from existing cash resources.\nSee our latest analysis for Consun Pharmaceutical Group.\nThe increased buyback plan comes after a strong run in the shares, with a 15.54% 1 month share price return and a 20.23% 3 month share price return helping support a very...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-valuation-check-after-e","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-valuation-check-after-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1606","BK1191","01681","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123581115","title":"CONSUN PHARMA (01681) Proposes to Repurchase Up to HK$300 Million in Company Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1123581115","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123581115?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:50","pubTimestamp":1769676637,"startTime":"0","endTime":"0","summary":"CONSUN PHARMA (01681) announced that on June 13, 2025, the Board of Directors resolved to implement a share repurchase plan, authorizing the buyback of shares on the open market at appropriate times...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607049877","title":"Consun Pharma Expands Share Buyback Program to HK$300 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049877","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049877?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:47","pubTimestamp":1769676460,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical  said it will expand its on-market share repurchase program to an aggregate cap of HK$300 million, following a board resolution, according to a Thursday Hong Kong bourse filing.The company had previously approved a HK$200 million buyback in June 2025 and has now authorised a further HK$100 million under the existing shareholder-approved general mandate.Consun said the repurchases will be funded from existing cash resources and conducted in the open market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607701256","title":"Consun Pharmaceutical - Implement Another Share Repurchase Program Increased up to Further HKD100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2607701256","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607701256?lang=en_us&edition=fundamental","pubTime":"2026-01-29 16:37","pubTimestamp":1769675839,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU03V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":-0.0161},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0858},{"period":"6month","weight":0.0364},{"period":"1year","weight":1.0906},{"period":"ytd","weight":0.0921}],"compareEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.0191},{"period":"3month","weight":-0.0098},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.2864},{"period":"ytd","weight":0.0102}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.045412},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016845},{"month":3,"riseRate":0.461538,"avgChangeRate":0.017217},{"month":4,"riseRate":0.769231,"avgChangeRate":0.063366},{"month":5,"riseRate":0.583333,"avgChangeRate":0.035442},{"month":6,"riseRate":0.416667,"avgChangeRate":0.002936},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010529},{"month":8,"riseRate":0.583333,"avgChangeRate":0.012771},{"month":9,"riseRate":0.583333,"avgChangeRate":0.028269},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025864},{"month":11,"riseRate":0.5,"avgChangeRate":0.008603},{"month":12,"riseRate":0.583333,"avgChangeRate":0.021467}],"exchange":"SEHK","name":"CONSUN PHARMA","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CONSUN PHARMA(01681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CONSUN PHARMA,01681,CONSUN PHARMA股票,CONSUN PHARMA股票老虎,CONSUN PHARMA股票老虎国际,CONSUN PHARMA行情,CONSUN PHARMA股票行情,CONSUN PHARMA股价,CONSUN PHARMA股市,CONSUN PHARMA股票价格,CONSUN PHARMA股票交易,CONSUN PHARMA股票购买,CONSUN PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CONSUN PHARMA(01681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}